Resume-aware faculty matching

Find professors who actually fit you

Review faculty evidence in public, then use the workspace to turn your background into a shortlist, outreach, and meeting prep.

Profile-awarePaper evidenceSix agents
Huiman Xie Barnhart

Huiman Xie Barnhart

· James B. Duke Distinguished Professor of Biostatistics & Bioinformatics

Duke University · Biostatistics and Bioinformatics

Active 1993–2026

h-index75
Citations24.6k
Papers38774 last 5y
Funding$32.5M1 active

Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.

See your match with Huiman Xie Barnhart — sign in to PhdFit.Sign in

About

Huiman Xie Barnhart is the James B. Duke Distinguished Professor of Biostatistics & Bioinformatics at Duke University. He also serves as a Professor of Biostatistics & Bioinformatics, the Associate Chair for Faculty Mentorship and Development, and is a member of the Duke Clinical Research Institute. His academic and professional roles are based at Duke's Department of Biostatistics and Bioinformatics, located at 2424 Erwin Road, Durham, NC. His research focuses on biostatistics and bioinformatics, contributing to the advancement of these fields through his leadership and scholarly work.

Research topics

  • Medicine
  • Chemistry
  • Internal medicine
  • Traditional medicine
  • Intensive care medicine
  • Food science
  • Gastroenterology

Selected publications

  • A revised electronic version of RUCAM for the diagnosis of DILI

    Hepatology · 2022 · 114 citations

    Background and Aims: Roussel Uclaf Causality Assessment Method (RUCAM) for DILI has been hindered by subjectivity and poor reliability. We sought to improve the RUCAM using data from the Drug-Induced Liver Injury Network (DILIN) and the Spanish DILI Registry, published literature, and it- erative computer modeling. Approach and Results: RUCAM criteria were updated, clarified, and com- puterized. We removed criteria 3 (risk factors) for lack of added value and cri- teria 4 because we felt it more…

  • HLA‐B*35:01 and Green Tea–Induced Liver Injury

    Hepatology · 2020 · 92 citations

    Background and Aims Herbal supplements, and particularly multi‐ingredient products, have become increasingly common causes of acute liver injury. Green tea is a frequent component in implicated products, but its role in liver injury is controversial. The aim of this study was to better characterize the clinical features, outcomes, and pathogenesis of green tea‐associated liver injury. Approach and Results Among 1,414 patients enrolled in the U.S. Drug‐Induced Liver Injury Network who underwent f…

  • Incidence of Idiosyncratic Drug-Induced Liver Injury Caused by Prescription Drugs

    Drug Safety · 2024-09-24 · 9 citations

    articleOpen access
  • Refinement of Hy Law Using the Drug-Induced Liver Injury Network Database

    The American Journal of Gastroenterology · 2024-10-18 · 7 citations

    articleOpen access

    INTRODUCTION: Hyman Zimmerman observed that hepatocellular (HC) drug-induced liver injury (DILI) with jaundice had a mortality rate of ≥ 10% (Hy Law). Hy Law does not specify the timing of liver tests nor the definition of HC DILI versus cholestatic or mixed (C/M) DILI. We aimed to assess the validity of Hy Law in the prospective DILI Network (DILIN) cohort. METHODS: Drugs with ≥10 confirmed DILI cases with jaundice were analyzed. Four permutations of Hy Law were applied: R ≥ 5 using initial (1)…

  • Clinical and HLA Associations of Fluoroquinolone-Induced Liver Injury: Results From the Drug-Induced Liver Injury Network

    The American Journal of Gastroenterology · 2025-04-10 · 6 citations

    articleOpen access

    INTRODUCTION: Fluoroquinolones (FQ) have a favorable safety profile, but the risk of drug-induced liver injury (DILI) is well described. The aim of this study was to identify clinical features and HLA genetic variants associated with FQ-DILI in a large national registry. METHODS: Analysis of FQ-DILI cases enrolled in DILI Network between 2004 and 2022. HLA class I and II alleles were sequenced by the Illumina MiSeq platform. RESULTS: Sixty-one cases (32 ciprofloxacin, 22 levofloxacin, 7 moxiflox…

Recent grants

Frequent coauthors

  • Evan R. Myers

    Duke University

    335 shared
  • Nicholas A. Cataldo

    314 shared
  • Peter G. McGovern

    311 shared
  • Sandra Ann Carson

    Yale University

    310 shared
  • William D. Schlaff

    Thomas Jefferson University

    309 shared
  • Michael P. Steinkampf

    308 shared
  • Michael P. Diamond

    308 shared
  • John E. Nestler

    European Gravitational Observatory

    308 shared

Education

  • PhD, Statistics

    University of Pittsburgh

    1992

Similar researchers at Duke University

  • Resume-aware match score
  • Save to shortlist
  • AI-drafted outreach

See your match with Huiman Xie Barnhart

PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.

  • Free to start
  • No credit card
  • 30-second signup